SULT1A1 and lung carcinoma: However, others studies reported that SULT1A1*2 isoform could confer not statistically significant reduced risks to bladder cancer (Hung et al., 2004) and colorectal cancer (Nowell et al., 2002), as well as a statistically significant lung cancer risk reduction in heterozygous individuals (Ihsan et al., 2011).